News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,194 Results
Type
Article (19452)
Company Profile (165)
Press Release (225573)
Multimedia
Podcasts (53)
Webinars (7)
Section
Business (64962)
Career Advice (261)
Deals (9751)
Drug Delivery (69)
Drug Development (35023)
Employer Resources (44)
FDA (7080)
Job Trends (6484)
News (117555)
Policy (11819)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1651)
Academic (1)
Accelerated approval (17)
Adcomms (13)
Allergies (73)
Alliances (18742)
ALS (80)
Alzheimer's disease (749)
Antibody-drug conjugate (ADC) (145)
Approvals (7371)
Artificial intelligence (274)
Autoimmune disease (89)
Automation (21)
Bankruptcy (63)
Best Places to Work (6129)
BIOSECURE Act (7)
Biosimilars (138)
Biotechnology (115)
Bladder cancer (93)
Brain cancer (25)
Breast cancer (330)
Cancer (2509)
Cardiovascular disease (270)
Career advice (241)
Career pathing (14)
CAR-T (156)
CDC (17)
Celiac Disease (1)
Cell therapy (430)
Cervical cancer (15)
Clinical research (31080)
Collaboration (991)
Company closure (1)
Compensation (401)
Complete response letters (20)
COVID-19 (1173)
CRISPR (73)
C-suite (454)
Cystic fibrosis (94)
Data (3667)
Decentralized trials (1)
Denatured (23)
Depression (69)
Diabetes (280)
Diagnostics (2464)
Digital health (24)
Diversity (8)
Diversity, equity & inclusion (18)
Drug discovery (152)
Drug pricing (122)
Drug shortages (19)
Duchenne muscular dystrophy (135)
Earnings (21474)
Editorial (24)
Employer branding (3)
Employer resources (45)
Events (37303)
Executive appointments (501)
FDA (8839)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (709)
Gene editing (145)
Generative AI (29)
Gene therapy (367)
GLP-1 (560)
Government (1767)
Grass and pollen (2)
Guidances (179)
Healthcare (8081)
HIV (41)
Huntington's disease (25)
IgA nephropathy (53)
Immunology and inflammation (103)
Immuno-oncology (30)
Indications (66)
Infectious disease (1302)
Inflammatory bowel disease (127)
Inflation Reduction Act (7)
Influenza (55)
Intellectual property (83)
Interviews (22)
IPO (4722)
IRA (27)
Job creations (788)
Job search strategy (208)
JPM (34)
Kidney cancer (10)
Labor market (19)
Layoffs (153)
Leadership (13)
Legal (1862)
Liver cancer (42)
Longevity (9)
Lung cancer (350)
Lymphoma (243)
Machine learning (23)
Management (15)
Manufacturing (412)
MASH (94)
Medical device (2867)
Medtech (2882)
Mergers & acquisitions (5473)
Metabolic disorders (710)
Multiple sclerosis (74)
NASH (12)
Neurodegenerative disease (148)
Neuropsychiatric disorders (38)
Neuroscience (1374)
NextGen: Class of 2026 (2272)
Non-profit (1826)
Now hiring (19)
Obesity (338)
Opinion (113)
Ovarian cancer (85)
Pain (122)
Pancreatic cancer (94)
Parkinson's disease (137)
Partnered (17)
Patents (162)
Patient recruitment (237)
Peanut (24)
People (24002)
Pharmaceutical (33)
Pharmacy benefit managers (16)
Phase 1 (8783)
Phase 2 (12583)
Phase 3 (12051)
Pipeline (2684)
Policy (153)
Postmarket research (1463)
Preclinical (3469)
Press Release (15)
Prostate cancer (123)
Psychedelics (15)
Radiopharmaceuticals (162)
Rare diseases (518)
Real estate (1681)
Recruiting (17)
Regulatory (10637)
Reports (14)
Research institute (1440)
Resumes & cover letters (21)
Rett syndrome (24)
RNA editing (11)
RSV (32)
Schizophrenia (81)
Series A (133)
Series B (103)
Sickle cell disease (75)
Special edition (9)
Spinal muscular atrophy (93)
Sponsored (18)
Startups (1455)
State (1)
Stomach cancer (7)
Supply chain (51)
Tariffs (53)
The Weekly (29)
Vaccines (409)
Venture capital (45)
Weight loss (220)
Women's health (42)
Worklife (3)
Date
Today (2)
Last 7 days (290)
Last 30 days (1106)
Last 365 days (14512)
2026 (1437)
2025 (14623)
2024 (16118)
2023 (17524)
2022 (21893)
2021 (22655)
2020 (20807)
2019 (17946)
2018 (13397)
2017 (12486)
2016 (11625)
2015 (12580)
2014 (8840)
2013 (7302)
2012 (7452)
2011 (7412)
2010 (5996)
Location
Africa (257)
Alabama (32)
Alaska (2)
Arizona (73)
Arkansas (3)
Asia (16601)
Australia (2258)
California (5115)
Canada (1235)
China (590)
Colorado (169)
Connecticut (254)
Delaware (230)
Europe (36752)
Florida (725)
Georgia (140)
Hawaii (1)
Idaho (15)
Illinois (410)
India (39)
Indiana (332)
Iowa (7)
Japan (318)
Kansas (54)
Kentucky (9)
Louisiana (12)
Maine (28)
Maryland (515)
Massachusetts (4214)
Michigan (51)
Minnesota (136)
Mississippi (1)
Missouri (65)
Montana (12)
Nebraska (4)
Nevada (34)
New Hampshire (16)
New Jersey (1828)
New Mexico (11)
New York (1438)
North Carolina (692)
North Dakota (6)
Northern California (2699)
Ohio (126)
Oklahoma (9)
Oregon (23)
Pennsylvania (998)
Puerto Rico (3)
Rhode Island (20)
South America (314)
South Carolina (9)
Southern California (1840)
Tennessee (50)
Texas (614)
United States (18576)
Utah (156)
Vermont (1)
Virginia (136)
Washington D.C. (46)
Washington State (437)
Wisconsin (52)
245,194 Results for "bridge medicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline
With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage pipeline and hunting for deals to build its return to growth.
February 6, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
January 15, 2026
·
3 min read
Press Releases
insitro Validates AI-Enabled POSH Platform in Nature Communications, Bridging Critical Gap in Drug Discovery
December 17, 2025
·
5 min read
In partnership with PII
Bridging Formulation and Device: Integrated Supply Chain Strategies for U.S. Pharma Manufacturing
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development with drug delivery device design—and leveraging a single‐vendor ecosystem—can deliver significant time, cost, and regulatory advantages for US‑focused drug products, according to industry experts.
December 8, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Samsung Bioepis’ European Whitepaper Proposes Solutions to Bridge Policy Gaps that Hinder Healthy Market Competition and Timely Access to Biosimilar Medicines
July 14, 2025
·
5 min read
Press Releases
Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated Perfusion of Donor Livers
January 20, 2026
·
5 min read
Press Releases
FDA Granted Hopstem’s hNPC01 for Chronic Ischemic Stroke Approval to Enter Phase 2/3 Adaptive Pivotal Clinical Trial with Bridging Study
January 21, 2026
·
5 min read
IN PARTNERSHIP WITH Pii, A JABIL COMPANY
Webinar: Bridging Formulation & Device | Integrated Supply Chain Strategies for US Pharma Manufacturing
Listen now for a high-level discussion on overcoming pharmaceutical supply chain challenges through end-to-end integration.
September 17, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
July 14, 2025
·
2 min read
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres’s Lab at the University of Colorado School of Medicine.
March 26, 2024
·
4 min read
1 of 24,520
Next
